Use of dexamethasone to reduce postoperative vomiting and pain after pediatric tonsillectomy procedures

Abdulhamid H Samarkandi1, Mussarat A Shaikh, Rana A Ahmad

  • 1Department of Anesthesia, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia.

Saudi Medical Journal
|December 2, 2004
PubMed

Insights

A single dose of dexamethasone significantly reduced post-operative vomiting and retching in children undergoing tonsillectomy. While not impacting pain or oral intake, dexamethasone demonstrated clear antiemetic properties in pediatric patients.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology
  • Surgical Outcomes

Background:

  • Post-tonsillectomy nausea and vomiting (PONV) are common complications in pediatric patients.
  • Effective management of PONV is crucial for patient recovery and satisfaction.
  • Dexamethasone is a corticosteroid with known antiemetic potential.

Purpose of the Study:

  • To evaluate the efficacy of a single pre-operative dose of dexamethasone (0.5mg/kg) in reducing post-operative vomiting and pain.
  • To assess the impact of dexamethasone on oral intake within 24 hours after pediatric tonsillectomy.
  • To determine the safety profile of peri-operative dexamethasone administration in children.

Main Methods:

  • A randomized, double-blind, placebo-controlled study involving 60 children (aged 2-12 years) undergoing tonsillectomy.
  • Patients received either intravenous dexamethasone (n=29) or saline placebo (n=31) at anesthetic induction.
  • Standardized anesthetic and surgical protocols were followed, with observation for vomiting, pain, antiemetic/analgesic use, and oral intake for 24 hours.

Main Results:

  • The incidence of vomiting was significantly lower in the dexamethasone group (37%) compared to the control group (74%) (P=0.016).
  • Retching occurred significantly less frequently in the dexamethasone group (3.4%) versus the control group (29%) (p=0.008).
  • No significant differences were observed between groups regarding the need for rescue antiemetics, time to first oral intake, or analgesic requirements.

Conclusions:

  • A single pre-operative dose of dexamethasone is safe and well-tolerated in pediatric tonsillectomy patients, with no adverse effects noted.
  • Dexamethasone exhibits significant antiemetic properties, effectively reducing the incidence of vomiting and retching post-tonsillectomy.
  • While not significantly improving pain control or oral intake, the antiemetic effect of dexamethasone is a valuable benefit in this patient population.
Abstract

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.